Mesalamine

Product manufactured by Northstar Rx Llc.

Application Nr Approved Date Route Status External Links
ANDA091640 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Mesalamine Delayed-Release Tablets Are Locally Acting 5-Aminosalicylic Acid (5-Asa) Indicated For The Induction Of Remission In Adults With Active, Mild To Moderate Ulcerative Colitis And For The Maintenance Of Remission Of Ulcerative Colitis. ( 1 ) Mesalamine Delayed-Release Tablets Are Indicated For The Induction Of Remission In Patients With Active, Mild To Moderate Ulcerative Colitis And For The Maintenance Of Remission Of Ulcerative Colitis.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Mesalamine MESALAMINE ZINC1688

Comments